Table 2. Procedural data.
N | BVF (N=81) | Control (N=79) | p-value | ||
THV type, % | SAPIEN 3 | 160 | 22 (18) | 29 (23) | 0.004 |
ALLEGRA | 2 (2) | 0 (0) | |||
Evolut R/Pro | 70 (57) | 59 (47) | |||
ACURATE neo | 1 (1) | 1 (1) | |||
Portico | 2 (2) | 0 (0) | |||
J-valve | 1 (1) | 0 (0) | |||
DFM | 0 (0) | 1 (1) | |||
Lotus | 0 (0) | 9 (7) | |||
THV size, mm | 160 | 23.7±1.7 | 24.8±2.3 | <0.001 | |
THV oversized in relation to SAV | 160 | 13 (16) | 0 | ||
Contrast, ml | 143 | 100±55 | 84±50 | 0.076 | |
Fluoroscopy time, min | 139 | 26.2±18.0 | 16.6±11.9 | <0.001 | |
Procedure duration, min | 138 | 87±42 | 57±25 | <0.001 | |
Cerebral protection | 159 | 31 (25) | 9 (7) | <0.001 | |
Access transfemoral | 158 | 94 (75) | 99 (77) | 0.34 | |
Balloon type for BVF | True dilatation | 81 | 88 (71) | ||
Atlas | 12 (10) | ||||
Balloon oversizing in relation to true ID | 79 | 2.8±1.1 | |||
Balloon size, mm | 79 | 21.8±1.8 | 21.1±2.0 | ||
Max balloon pressure, atm | 65 | 15.8±3.6 | |||
Final mean transvalvular gradient, mmHg | 145 | 10.8±5.9 | 15.8±6.8 | <0.001 |